| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |